Deutscher Schmerzkongress 2018
Kalender Liste Personen Favoriten
zur Liste
Dr. Thomas Weiser
Sanofi-Aventis Deutschland GmbH Germany
  • Vortrag Ibuprofen/caffeine is a superior analgesic to Ibuprofen, caffeine and placebo: A randomized, double-blind, placebo-controlled trial in patients with postoperative dental pain Speaker
    Datum: 18.10.2018 , Zeit: 14:15 | Thema:
    Details
  • Vortrag Wie schätzen Allgemeinmediziner (AM), Apotheker (AP) und Pharmazeutisch-technische Assistenten (PTA) Kopfschmerz durch Medikamentenübergebrauch (MOH) ein? Ergebnisse einer internetbasierten Befragung. Speaker
    Datum: 19.10.2018 , Zeit: 14:39 | Thema:
    Details
  • Vortrag Time course of patient perceptions in a double-blind, randomized, placebo-controlled trial investigating efficacy of capsaicin (0.05%) cream (Finalgon®) for the treatment of soft tissue rheumatic pain over 21 days Speaker
    Datum: 19.10.2018 , Zeit: 14:39 | Thema:
    Details
  • Vortrag Cumulative proportion of responders analysis (CPRA) of a randomized, controlled trial investigating the effects oft he fixed dose combination (FDC) Nicoboxil/Nonivamide (Finalgon®), Nicoboxil, Nonivamide and placebo ointment fort he treatment of acute low Speaker
    Datum: 19.10.2018 , Zeit: 14:45 | Thema:
    Details
  • Vortrag A randomised, PLACEBO controlled trial investigating efficacy and saftey of topical Nonivamide/Nicoboxil (Finalgon®) fixed dose combination (FDC) in acute low back pain (ALBP) Speaker
    Datum: 19.10.2018 , Zeit: 14:51 | Thema:
    Details